| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Cytogenetics and Molecular Genetics, Womens and Childrens Hospital, Adelaide, South Australia 5006, Australia [M. M., K. R., E. W., S. D., H. E., M. F., L. H., J. N., E. B., R. I. R.]; Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia [D. V.]; and Department of Genetics, The University of Adelaide, South Australia 5000, Australia [R. I. R.]
It has been proposed that common aphidicolin-inducible fragile sites, in general, predispose to specific chromosomal breakage associated with deletion, amplification, and/or translocation in certain forms of cancer. Although this appears to be the case for the fragile site FRA3B and may be the case for FRA7G, it is not yet clear whether this association is a general property of this class of fragile site. The major aim of the present study was to determine whether the FRA16D chromosomal fragile site locus has a role to play in predisposing DNA sequences within and adjacent to the fragile site to DNA instability (such as deletion or translocation), which could lead to or be associated with neoplasia. We report the localization of FRA16D within a contig of cloned DNA and demonstrate that this fragile site coincides with a region of homozygous deletion in a gastric adenocarcinoma cell line and is bracketed by translocation breakpoints in multiple myeloma, as reported previously (Chesi, M., et al., Blood, 91: 44574463, 1998). Therefore, given similar findings at the FRA3B and FRA7G fragile sites, it is likely that common aphidicolin-inducible fragile sites exhibit the general property of localized DNA instability in cancer cells.
This article has been cited by other articles:
![]() |
D. Kumari, V. Somma, A. J. Nakamura, W. M. Bonner, E. D'Ambrosio, and K. Usdin The role of DNA damage response pathways in chromosome fragility in Fragile X syndrome Nucleic Acids Res., July 1, 2009; 37(13): 4385 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Jenner, P. E. Leone, B. A. Walker, F. M. Ross, D. C. Johnson, D. Gonzalez, L. Chiecchio, E. Dachs Cabanas, G. Paolo Dagrada, M. Nightingale, et al. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma Blood, November 1, 2007; 110(9): 3291 - 3300. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Donati, G. Fontanini, M. Dell'Omodarme, M. C. Prati, S. Nuti, M. Lucchi, A. Mussi, M. Fabbri, F. Basolo, C. M. Croce, et al. WWOX Expression in Different Histologic Types and Subtypes of Non-Small Cell Lung Cancer Clin. Cancer Res., February 1, 2007; 13(3): 884 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. El Achkar, M. Gerbault-Seureau, M. Muleris, B. Dutrillaux, and M. Debatisse Premature condensation induces breaks at the interface of early and late replicating chromosome bands bearing common fragile sites PNAS, December 13, 2005; 102(50): 18069 - 18074. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Glover, M. F. Arlt, A. M. Casper, and S. G. Durkin Mechanisms of common fragile site instability Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R197 - R205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Finnis, S. Dayan, L. Hobson, G. Chenevix-Trench, K. Friend, K. Ried, D. Venter, E. Woollatt, E. Baker, and R. I. Richards Common chromosomal fragile site FRA16D mutation in cancer cells Hum. Mol. Genet., May 15, 2005; 14(10): 1341 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Arlt, B. Xu, S. G. Durkin, A. M. Casper, M. B. Kastan, and T. W. Glover BRCA1 Is Required for Common-Fragile-Site Stability via Its G2/M Checkpoint Function Mol. Cell. Biol., August 1, 2004; 24(15): 6701 - 6709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Aqeilan, T. Kuroki, Y. Pekarsky, O. Albagha, F. Trapasso, R. Baffa, K. Huebner, P. Edmonds, and C. M. Croce Loss of WWOX Expression in Gastric Carcinoma Clin. Cancer Res., May 1, 2004; 10(9): 3053 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Jackson, A. V. Trevino, M. C. Herzig, T. S. Herman, and J. M. Woynarowski Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells Nucleic Acids Res., November 1, 2003; 31(21): 6354 - 6364. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zlotorynski, A. Rahat, J. Skaug, N. Ben-Porat, E. Ozeri, R. Hershberg, A. Levi, S. W. Scherer, H. Margalit, and B. Kerem Molecular Basis for Expression of Common and Rare Fragile Sites Mol. Cell. Biol., October 15, 2003; 23(20): 7143 - 7151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Corbin, M. E. Neilly, R. Espinosa III, E. M. Davis, T. W. McKeithan, and M. M. Le Beau Identification of Unstable Sequences within the Common Fragile Site at 3p14.2: Implications for the Mechanism of Deletions within Fragile Histidine Triad Gene/Common Fragile Site at 3p14.2 in Tumors Cancer Res., June 1, 2002; 62(12): 3477 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Jamieson, R. Perveen, B. Kerr, M. Carette, J. Yardley, E. Heon, M. G. Wirth, V. van Heyningen, D. Donnai, F. Munier, et al. Domain disruption and mutation of the bZIP transcription factor, MAF,associated with cataract, ocular anterior segment dysgenesis and coloboma Hum. Mol. Genet., January 1, 2002; 11(1): 33 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bednarek, C. L. Keck-Waggoner, R. L. Daniel, K. J. Laflin, P. L. Bergsagel, K. Kiguchi, A. J. Brenner, and C. M. Aldaz WWOX, the FRA16D Gene, Behaves as a Suppressor of Tumor Growth Cancer Res., November 1, 2001; 61(22): 8068 - 8073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. W. Paige, K. J. Taylor, C. Taylor, S. G. Hillier, S. Farrington, D. Scott, D. J. Porteous, J. F. Smyth, H. Gabra, and J. E. V. Watson WWOX: A candidate tumor suppressor gene involved in multiple tumor types PNAS, September 25, 2001; 98(20): 11417 - 11422. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiraishi, T. Druck, K. Mimori, J. Flomenberg, L. Berk, H. Alder, W. Miller, K. Huebner, and C. M. Croce Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit PNAS, April 18, 2001; (2001) 91095898. [Abstract] [Full Text] |
||||
![]() |
A.-M. Cleton-Jansen, D. F. Callen, R. Seshadri, S. Goldup, B. McCallum, J. Crawford, J. A. Powell, C. Settasatian, H. van Beerendonk, E. W. Moerland, et al. Loss of Heterozygosity Mapping at Chromosome Arm 16q in 712 Breast Tumors Reveals Factors that Influence Delineation of Candidate Regions Cancer Res., February 1, 2001; 61(3): 1171 - 1177. [Abstract] [Full Text] |
||||
![]() |
E. C. Thorland, S. L. Myers, D. H. Persing, G. Sarkar, R. M. McGovern, B. S. Gostout, and D. I. Smith Human Papillomavirus Type 16 Integrations in Cervical Tumors Frequently Occur in Common Fragile Sites Cancer Res., November 1, 2000; 60(21): 5916 - 5921. [Abstract] [Full Text] |
||||
![]() |
K. Ried, M. Finnis, L. Hobson, M. Mangelsdorf, S. Dayan, J. K. Nancarrow, E. Woollatt, G. Kremmidiotis, A. Gardner, D. Venter, et al. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells Hum. Mol. Genet., July 1, 2000; 9(11): 1651 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. W. Paige, K. J. Taylor, A. Stewart, J. G. Sgouros, H. Gabra, G. C. Sellar, J. F. Smyth, D. J. Porteous, and J. E. V. Watson A 700-kb Physical Map of a Region of 16q23.2 Homozygously Deleted in Multiple Cancers and Spanning the Common Fragile Site FRA16D Cancer Res., March 1, 2000; 60(6): 1690 - 1697. [Abstract] [Full Text] |
||||
![]() |
J. M. Woynarowski, A. V. Trevino, K. A. Rodriguez, S. C. Hardies, and C. J. Benham AT-rich Islands in Genomic DNA as a Novel Target for AT-specific DNA-reactive Antitumor Drugs J. Biol. Chem., October 26, 2001; 276(44): 40555 - 40566. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiraishi, T. Druck, K. Mimori, J. Flomenberg, L. Berk, H. Alder, W. Miller, K. Huebner, and C. M. Croce Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit PNAS, May 8, 2001; 98(10): 5722 - 5727. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |